Markets:

Overview

News

Currencies

International

Treasuries

Soligenix, Inc. - Common Stock (NQ:SNGX)

0.3707 +0.0008 (+0.22%)

Streaming Delayed Price Updated: 9:47 AM EDT, Jul 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Soligenix, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Why Are Soligenix Shares Trading Higher Today ↗

May 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 04, 2023

Via Benzinga

Soligenix (NASDAQ: SNGX) Reports Strong Clinical Results from Compatibility Study of HyBryte as a Treatment for Cutaneous T-Cell Lymphoma

May 04, 2023

Soligenix, Inc. (NASDAQ: SNGX) is engaged as a late-stage biopharmaceutical company that is focused on the research, development and commercialization

Via Spotlight Growth

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 20, 2023

Via Benzinga

FDA Asks For Additional Successful Trial To Approve Soligenix's Rare Cancer Candidate ↗

April 14, 2023

Via Benzinga

Why Are Soligenix Shares Plummeting Today? ↗

February 14, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 14, 2023

On Friday, 127 companies set new 52-week lows.

Via Benzinga

This Combination Therapy Could Help Change Cancer Treatment — Benzinga Looks Deeper Into Allarity Therapeutics' Trial, Including An Interview With An Oncology Expert ↗

April 13, 2023

Allarity Therapeutics (NASDAQ: ALLR) dosed its first patient in Phase 1b of its clinical trial for the novel combination therapy of two drug

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 11, 2023

On Tuesday, 65 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 10, 2023

Monday's session saw 114 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 27, 2023

During Monday's session, 56 companies made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 24, 2023

On Friday, 135 companies reached new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 21, 2023

On Tuesday, 74 companies achieved new lows for the year.

Via Benzinga

Soligenix, Inc: Vital Vaccine Development Program has Potential to Address Future Marburg Virus Outbreaks

February 16, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Death

Stocks That Hit 52-Week Lows On Tuesday ↗

February 28, 2023

During Tuesday, 79 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 15, 2023

Via Benzinga

Nasdaq Turns Higher; Soligenix Shares Plunge ↗

February 14, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 50 points on Tuesday. The Dow traded down 0.16% to 34,191.46 while the NASDAQ rose 0.51% to 11,952.38. The...

Via Benzinga

Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 14, 2023

Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.

Via Benzinga

Crude Oil Down 1%; SkyWater Technology Shares Spike Higher ↗

February 14, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 250 points on Tuesday. The Dow traded down 0.79% to 33,975.65 while the NASDAQ fell 0.59% to 11,821.20. The S&P...

Via Benzinga

OXY Stock Alert: Occidental Petroleum Receives Goldman Sachs Upgrade ↗

February 14, 2023

Occidental Petroleum (OXY) stock is on the rise Tuesday following an bullish upgrade and new price target from Goldman Sachs.

Via InvestorPlace

Why Is Soligenix (SNGX) Stock Down 35% Today? ↗

February 14, 2023

Soligenix (SNGX) stock is falling hard on Tuesday with heavy trading after the company's HyBryte cancer drug was rejected by the FDA.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Tuesday ↗

February 14, 2023

During Tuesday, 40 stocks hit new 52-week lows.

Via Benzinga

Dow Falls 150 Points; US Consumer Prices Rise 0.5% In January ↗

February 14, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.46% to 34,089.44 while the NASDAQ fell 0.42%...

Via Benzinga

Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket ↗

February 14, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 14, 2023

It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday!

Via InvestorPlace

Stocks That Hit 52-Week Lows On Friday ↗

February 10, 2023

During Friday, 48 stocks hit new 52-week lows.

Via Benzinga

Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024

January 12, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 29, 2022

Via Benzinga

Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session ↗

December 27, 2022

Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C.

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.